{
    "table_name": "CPTAC.QUANT_PHOSPHOPROTEOME_AML_EX_VIVO_DRUG_RESPONSE_COMBINATION_TREATMENT_PDC_CURRENT",
    "table_fullname": "CPTAC_PDC.CPTAC.QUANT_PHOSPHOPROTEOME_AML_EX_VIVO_DRUG_RESPONSE_COMBINATION_TREATMENT_PDC_CURRENT",
    "column_names": [
        "aliquot_run_metadata_id",
        "refseq_id",
        "sample_id",
        "aliquot_id",
        "protein_abundance_log2ratio",
        "study_name",
        "aliquot_submitter_id",
        "phosphorylation_sites",
        "case_id"
    ],
    "column_types": [
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "FLOAT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT"
    ],
    "description": [
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null
    ],
    "sample_rows": [
        {
            "case_id": "e4796a23-6e79-4159-8547-d7fbe13098c9",
            "sample_id": "dddc3c0f-af7c-453b-9929-fe6896297df1",
            "aliquot_id": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
            "aliquot_submitter_id": "15-00756-1",
            "aliquot_run_metadata_id": "0b52440e-7094-4574-926d-b2720e6abc40",
            "study_name": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
            "protein_abundance_log2ratio": 1.322,
            "refseq_id": "NP_000876.3",
            "phosphorylation_sites": "s424"
        },
        {
            "case_id": "e4796a23-6e79-4159-8547-d7fbe13098c9",
            "sample_id": "dddc3c0f-af7c-453b-9929-fe6896297df1",
            "aliquot_id": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
            "aliquot_submitter_id": "15-00756-1",
            "aliquot_run_metadata_id": "0b52440e-7094-4574-926d-b2720e6abc40",
            "study_name": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
            "protein_abundance_log2ratio": -0.387,
            "refseq_id": "NP_001001998.1",
            "phosphorylation_sites": "s13"
        },
        {
            "case_id": "e4796a23-6e79-4159-8547-d7fbe13098c9",
            "sample_id": "dddc3c0f-af7c-453b-9929-fe6896297df1",
            "aliquot_id": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
            "aliquot_submitter_id": "15-00756-1",
            "aliquot_run_metadata_id": "0b52440e-7094-4574-926d-b2720e6abc40",
            "study_name": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
            "protein_abundance_log2ratio": -1.9185,
            "refseq_id": "NP_001004304.1",
            "phosphorylation_sites": "s70"
        },
        {
            "case_id": "e4796a23-6e79-4159-8547-d7fbe13098c9",
            "sample_id": "dddc3c0f-af7c-453b-9929-fe6896297df1",
            "aliquot_id": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
            "aliquot_submitter_id": "15-00756-1",
            "aliquot_run_metadata_id": "0b52440e-7094-4574-926d-b2720e6abc40",
            "study_name": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
            "protein_abundance_log2ratio": -1.7886,
            "refseq_id": "NP_001006945.1",
            "phosphorylation_sites": "t681"
        },
        {
            "case_id": "e4796a23-6e79-4159-8547-d7fbe13098c9",
            "sample_id": "dddc3c0f-af7c-453b-9929-fe6896297df1",
            "aliquot_id": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
            "aliquot_submitter_id": "15-00756-1",
            "aliquot_run_metadata_id": "0b52440e-7094-4574-926d-b2720e6abc40",
            "study_name": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
            "protein_abundance_log2ratio": -1.9657,
            "refseq_id": "NP_001020271.1",
            "phosphorylation_sites": "s26"
        }
    ]
}